Dr. Cole K. Nishikawa, MD

Dr. Nishikawa practices at Pali Momi Medical Center in Aiea, Hawaii, part of Hawaiʻi Pacific Health.

Dr. Nishikawa's NPI, 1245611912, was assigned on June 17, 2015. Dr. Nishikawa holds Hawaii license 20965.

Dr. Nishikawa's primary practice is Pali Momi Medical Center, at 98-1079 Moanalua Road, Aiea, HI 96701 in Honolulu County. The practice phone is (808) 486-6000.

Dr. Nishikawa's primary practice is Pali Momi Medical Center in Aiea, Hawaii, part of Hawaiʻi Pacific Health. Dr. Nishikawa is also affiliated with NorthBay Medical Center. The medical group on file is NorthBay Medical Center. Dmand AI also links Dr. Nishikawa to 3 more medical groups, 1 clinical lab and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nishikawa practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Nishikawa's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Nishikawa is licensed in Hawaii.

CMS data shows 600 Medicare services from Dr. Nishikawa across 11 procedure codes in 2024, for 188 Medicare patients. Medicare paid $95,046 for them.

CMS counts 188 Medicare patients who saw Dr. Nishikawa in 2024. The largest group is 75 to 84, with 68 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 5.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nishikawa's median patient age at 69, with 40% women.

In 2024, Dr. Nishikawa wrote 212 Medicare Part D claims for 84 patients. 83% of them were for generic drugs. CMS names the drug for 191 of them, across 4 drugs with 11 or more claims each, at $4,760 in total drug cost. In 2023, CMS named 144 claims across 3 drugs.

Dr. Nishikawa accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 104 general payments to Dr. Nishikawa from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 63% of the total. Abbott Laboratories paid the most, $4,031.